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ABSTRACT 
 
Background: This study was done in Ahmed Qasim Hospital, from January to 
June 2005.  
Objectives: We studied the correlation between clinical presentation and 
angiographic findings in patients with coronary artery disease. 
Method: We studied 105 patients who underwent coronary angiography in 
Ahmed Qasim Hospital , from January to June 2005.  
56% were males, 44% were females. Ages 30-85 (mean: 59). 
The lesions were classified into simple (34%) and complex (66%) according to 
Ambrose’s modified criteria, and into single, two or three vessel disease. 
Results: 87 patients had angina; of this group 41 had established angiographic 
findings. 
There was no difference in lesion morphology or number of diseased vessels in 
those with stable and unstable angina. 
30 patients had diabetes, 75 were not diabetics. Complex lesions were more 
common in diabetics (70%) against (63%) for non diabetics. Three vessel disease 
was more prevalent in diabetics (43%) against (22%) for non diabetics. 
In 16 patients with history of MI the presence of three vessel disease was 
significant (75%). 
Conclusion: The morphology of the lesion was not correlated to type of angina in 
our study. Diabetes is associated with more extensive coronary involvement.   
Myocardial infarction is more common in patients with three vessel disease.
 ﻣﻠﺨﺺ اﻷﻃﺮوﺣﺔ
 
   . 5002ﻗﺎﺴﻡ ﻓﻲ ﺍﻟﻔﺘﺭﺓ ﻤﻥ ﻴﻨﺎﻴﺭ ﺤﺘﻰ ﻴﻭﻨﻴﻭ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺒﻤﺴﺘﺸﻔﻰ ﺃﺤﻤﺩ  ﺃﺠﺭﻴﺕ
هﺪﻓﺖ اﻟﺪراﺳﺔ إﻟﻰ ﻣﻌﺮﻓﺔ اﻟﻌﻼﻗﺔ  ﺑﻴﻦ ﻃﺒﻴﻌﺔ اﻻﻋﺮاض اﻟﺴﺮﻳﺮﻳﺔ و ﻧﺘﺎﺋﺞ  ﻗﺴﻄﺮةاﻟﺸﺮاﻳﻴﻦ 
   .  اﻟﺘﺎﺟﻴﺔ ﻋﻨﺪ ﻣﺮﺿﻰ إﻗﻔﺎر اﻟﻘﻠﺐ
         
% 44و اﻹﻧﺎث % 65 ﻣّﺜﻞ اﻟﺬآﻮر . ﻣﺮﻳﺾ ﻣﻦ ﻣﺮﺿﻰ إﻗﻔﺎر اﻟﻘﻠﺐ501        ﺗﻤﺖ دراﺳﺔ 
  . ﻋﺎﻣًﺎ58 و 03رهﻢ ﺑﻴﻦ ﺗﺮاوﺣﺖ أﻋﻤﺎو
وﻓﻘﺎ ﻟﺘﺼﻨﻴﻒ أﻣﺒﺮوس % 66و ﻣﺮآﺒﺔ % 43 و ﺗﻢ ﺗﻘﺴﻴﻢ إﺻﺎﺑﺎت اﻟﺸﺮاﻳﻴﻦ اﻟﺘﺎﺟﻴﺔ إﻟﻰ ﺑﺴﻴﻄﺔ 
  .واﻳﻀﺎ ﺣﺴﺐ ﻋﺪد اﻟﺸﺮاﻳﻴﻦ اﻟﻤﺼﺎﺑﺔ
 ﻣﺮﻳﺾ ﻓﻘﻂ ﻟﺪﻳﻬﻢ 14 ﻣﺮﻳﺾ ﻳﻌﺎﻧﻮن ﻣﻦ اﻟﺨﻨﺎق اﻟﺼﺪري، 78       إﺣﺘﻮت اﻟﺪراﺳﺔ ﻋﻠﻰ 
  .إﺻﺎﺑﺎت واﺿﺤﺔ ﺑﺎﻟﺸﺮاﻳﻴﻦ اﻟﺘﺎﺟﻴﺔ
  
اﻟﺪراﺳﺔ ﻟﻢ ﻳﻮﺟﺪ ﻓﺮق ﺑﻴﻦ ﻧﺴﺒﺔ اﻹﺻﺎﺑﺎت اﻟﺒﺴﻴﻄﺔ و اﻟﻤﺮآﺒﺔ ﻓﻲ ﺣﺎﻻت اﻟﺨﻨﺎق     ﻓﻲ هﺬﻩ 
  .اﻟﺼﺪري اﻟﻤﺴﺘﻘﺮة و ﺗﻠﻚ ﻏﻴﺮاﻟﻤﺴﺘﻘﺮة
 ﻣﺮﻳﻀًﺎ ﻳﻌﺎﻧﻮن ﻣﻦ إرﺗﻔﺎع اﻟﺴﻜﺮ ﻓﻲ اﻟﺪم و هﺆﻻء آﺎﻧﺖ ﻟﺪﻳﻬﻢ ﻧﺴﺒﺔ أآﺒﺮ ﻣﻦ اﻹﺻﺎﺑﺎت ﺛﻼﺛﻮن
ﻺﺻﺎﺑﺔ اﻟﺜﻼﺛﻴﺔ ﻟ% 34و أﻳﻀًﺎ ﻧﺴﺒﺔ أﻋﻠﻰ . ﻟﻐﻴﺮ ﻣﺮﺿﻰ اﻟﺴﻜﺮي% 36ﻣﻘﺎﺑﻞ % 07اﻟﻤﺮآﺒﺔ 
  .ﻟﻐﻴﺮ ﻣﺮﺿﻰ اﻟﺴﻜﺮي%% 22ﻟﻠﺸﺮاﻳﻴﻦ ﻣﻘﺎﺑﻞ 
  %.57 ﻣﺮﻳﺾ ﻣﺼﺎﺑﻮن ﺑﺈﺣﺘﺸﺎء اﻟﻘﻠﺐ ﺳﺎﺑﻘًﺎ آﺎﻧﺖ ﻧﺴﺒﺔ اﻻﺻﺎﺑﺔ اﻟﺜﻼﺛﻴﺔ 61 ﻓﻲ 
ﺧﻠﺼﺖ هﺬﻩ اﻟﺪراﺳﺔ اﻟﻰ ﻋﺪم وﺟﻮد ﻋﻼﻗﺔ ﺑﻴﻦ ﺷﻜﻞ اﻻ ﺻﺎﺑﺔ ﺑﺎﻟﺸﺮاﻳﻴﻦ و ﻧﻮع اﻟﺨﻨﺎق   
و اﻹﺣﺘﺸﺎء . ﻮﻋًﺎ ﺑﻤﺮﺿﻰ اﻟﺴﻜﺮيو إﻟﻰ أن اﻻﺻﺎﺑﺎت اﻟﻤﺮآﺒﺔ و اﻟﺜﻼﺛﻴﺔ أآﺜﺮ ﺷﻴ. اﻟﺼﺪرى
 .اﻟﻘﻠﺒﻲ أآﺜﺮ ﺷﻴﻮﻋًﺎ ﻟﺪى اﻟﻤﺼﺎﺑﻴﻦ ﻟﺪى اﻟﻤﺮﺿﻰ أﺻﺤﺎب اﻹﺻﺎﺑﺎت اﻟﺜﻼﺛﻴﺔ
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CHAPTER ONE
INTRODUCTION 
& LITERATURE REVIEW 
 
Coronary artery disease comprises a wide spectrum of conditions, ranging 
from chronic stable angina to acute myocardial infarction.  
Several studies in the past 15 years have described the 
angiographic morphology of coronary lesions in acute coronary 
syndromes. [1-5] 
In unstable angina or acute myocardial infarction eccentric, irregular, 
with possible presence of thrombus lesions are more frequent and 
constitute the so-called complex lesions. 
They are usually due to the fissuring or rupture of atherosclerotic plaque 
and sometimes cause a lower degree of stenosis in the coronary arteries. 
In chronic stable angina, concentric and regular stenoses are the most 
frequent lesions and are called simple lesions. Usually, these lesions 
cause a greater degree of stenosis in the coronary arteries. 
 
There are several studies in the international literature, which describe the 
correlation of the coronary lesion morphology with clinical presentation. [6-
10] 
Coronary Artery Disease 
 
Coronary artery atherosclerosis is the principal cause of coronary artery disease (CAD) 
and is the single largest killer of both men and women [11]. 
CAD should be suspected in a patient with any evidence of cardiac ischemia, which 
commonly manifest as chest pain. This finding is especially suggestive when it is 
triggered by exertion, exposure to cold, or stress and when it radiates to left arm, jaw 
or epigastric area.  
Cardiac ischemia also may present without chest pain. Patients may have palpitations 
or unexpected or disproportionate dyspnoea triggered by exertion. Ischemia may also 
be asymptomatic, with or without ECG changes.  
Intervention before symptoms manifest is termed primary prevention; afterwards, it is 
termed secondary prevention.  
EPIDEMIOLOGY 
Prevalence  
For men, the reported prevalence of coronary heart disease increases with age from 
7% at ages 40 to 49 years to 13% at 50 to 59 years, 16% at 60 to 69 years, and 22% 
at 70 to 79 years. The corresponding estimates for women are substantially lower than 
for men: 5, 8, 11, and 14%, respectively. 
Incidence  •  For persons aged 40-60 years, the lifetime risk of development CHD is 
49 percent in men and 32 percent in women. For those reaching age 70 years, the 
lifetime risk is 35 percent in men and 24 percent in women.  • For total coronary 
events, the incidence rises steeply with age, with women lagging behind men by 10 
years. 
Mortality  Coronary heart disease is the leading cause of death in adults in the United 
States, accounting for about one-third of all deaths in subjects over age 35 [12]. The 
death rate is higher in men than in women (three times higher at ages 25 to 34, falling 
to 1.6 times at ages 75 to 84) and in blacks compared to whites, an excess that 
disappears by age 75. 
PATHOGENESIS OF ATHEROSCLEROSIS  
 
– Atherosclerosis is responsible for almost all cases of CHD. This insidious process 
begins with fatty streaks which are first seen in adolescence; these lesions progress 
into plaques in early adulthood, and culminate in thrombotic occlusions and coronary 
events in middle age and later life.  
 
HISTOLOGY – The initial lesion in atherosclerosis involves the intima of the artery 
and begins in childhood with the development of fatty streaks.  
  Fatty streaks – The first phase in atherosclerosis histologically presents as focal 
thickening of the intima with an increase in smooth muscle cells and extracellular 
matrix [13]. These smooth muscle cells migrate and proliferate within the intima. This 
is followed by accumulation of intracellular lipid deposits or extracellular lipids or 
both, which produce the fatty streak.  
The smooth muscle cells within the fatty streak are susceptible to apoptosis which is 
associated with further macrophage infiltration and cytoplasmic remnants that can 
calcify, perhaps contributing to the transition of fatty streaks into atherosclerotic 
plaques [14]. 
 
  Fibrous plaque – The fibrous plaque evolves from the fatty streak via 
accumulation of connective tissue with an increased number of smooth muscle cells 
ladened with lipids and often a deeper extracellular lipid pool. 
 
Plaque rupture – Atherosclerosis is generally asymptomatic until the plaque 
stenosis exceeds 70 or 80 percent which can produce a critical reduction in flow). 
These large lesions can produce typical symptoms of angina pectoris. However, 
clinical reports suggest that acute coronary syndromes (are due to rupture of 
plaques with less than 50 percent stenosis [15]. Thus, recent studies have focused on 
the anatomic aspects of these smaller lesions that render them unstable and likely to 
fissure, rupture, or dissect with resulting thrombosis [15-18] .Coronary angiography 
often delineates an irregular surface of the plaque in patients with unstable 
symptoms [17]. 
(Multiple factors contribute to the pathogenesis of atherosclerosis including 
abnormalities in lipid metabolism, endothelial dysfunction, inflammatory and 
immunologic factors, plaque rupture, and smoking.)  
RISK FACTORS  
Risk factors for CAD are classified as modifiable or unmodifiable. Modifiable risk 
factors include smoking, active or passive; hypertension; hyperlipidemia; (high total 
cholesterol and LDL-cholesterol, low high HDL, and high triglyceride levels); diabetes; 
abdominal obesity; sedentary lifestyle. High homocysteine level is suspected to be 
another risk factor. Unmodifiable risk factors include age, male sex, and family 
history.  
Aggressive lowering of cholesterol levels has reduced individual morbidity and 
mortality rates but not the overall cardiovascular death rate.  
ESTABLISHED RISK FACTORS FOR CORONARY HEART DISEASE  
 
Lipids – The serum total cholesterol concentration is a clear risk factor for coronary 
heart disease, the risk of CHD progressively increased with higher values for serum 
total cholesterol. 
More recent data emphasize the advantages in estimating lipid fractions, such as 
LDL and HDL, in addition to total cholesterol. Higher LDL cholesterol concentrations 
have been associated with an increased incidence of coronary artery disease in a 
large number of studies [19]. The following criteria are used for serum LDL-
cholesterol concentrations [20]: 
  •  High-risk - Above 160 mg/dL (>4.1 mmol/L) 
  •  Borderline high-risk - 130 to 159 mg/dL (3.4 to 4.1 mmol/L) 
  •  Desirable - Below 130 mg/dL (<3.4 mmol/L) 
 
On the other hand, serum HDL-cholesterol is inversely associated with coronary 
heart disease incidence [21] .Data from the Framingham Heart Study suggest that the 
risk for myocardial infarction increases by about 25 percent for every 5 mg/dL (0.13 
mmol/L) decrement below median values for men and women.  
The total cholesterol-to-HDL-cholesterol ratio represents a simple, efficient way to 
estimate coronary disease risk [22]: 
  •  Among men, a ratio of 6.4 or more identified a group at 2 to 14 percent greater 
risk than predicted from serum total or LDL-cholesterol 
  •  Among women, a ratio of 5.6 or more identified a group at 25 to 45 percent 
greater risk than predicted from serum total or LDL-cholesterol 
The roles of hypertriglyceridemia and elevated levels of Lipoprotein(a) as 
determinants of cardiovascular risk are less clear. 
  Treatment of hyperlipidemia – Recommendations for lipid evaluation and therapy 
in adults were formulated by an expert committee of the National Cholesterol 
Education Program and published in 1993[23]. Stepped care for abnormal lipid levels  
includes dietary restriction of fat and cholesterol, and recommends medications 
when certain LDL cholesterol levels are exceeded despite dietary interventions and 
other lifestyle modifications . 
A number of clinical trials have demonstrated that reductions in total and LDL-
cholesterol levels reduce coronary events and mortality when given for primary 
prevention[24,25] and equally in secondary prevention (after MI), including those with 
average levels of total, LDL and HDL cholesterol of 209 mg/dL, 139 mg/dL, and 39 
mg/dL (5.4, 3.6, and 1.0 mmol/L) [26] 
. 
Hypertension – Hypertension and left ventricular hypertrophy are well-established 
risk factors for adverse cardiovascular outcomes, including CHD, CHD mortality, 
stroke, congestive heart failure, and sudden death [27-28]. Systolic blood pressure is at 
least as powerful a coronary risk factor as the diastolic blood pressure [29] and 
isolated systolic hypertension is now established as a major hazard for coronary 
heart disease and stroke [30] . 
However, while controlled trials have demonstrated clear benefits with blood 
pressure reduction in terms of stroke and heart failure risk, they have not 
consistently demonstrated a benefit in coronary events, particularly in patients with 
mild hypertension [31] . 
 
Glucose intolerance and diabetes mellitus – Insulin resistance, hyperinsulinemia, 
and glucose intolerance appear to promote atherosclerosis .And are powerful 
contributors to cardiovascular events, particularly in women[32]. 
Diabetics have a greater burden of other atherogenic risk factors than nondiabetics, 
including hypertension, hypertriglyceridemia, increased total-to-HDL-cholesterol 
ratio, and elevated plasma fibrinogen. 
Thus, the guidelines published by the National Cholesterol Education Program and 
the sixth Joint National Committee have provided a framework to treat coronary risk 
factors aggressively in diabetics [23,27]. In addition, there is increasing evidence of the 
value to aggressive blood pressure control in diabetics.   
 
Estrogen deficiency – The incidence of CHD increases in women after 
menopause, an effect that is thought to be secondary to hypoestrogenemia. 
Hormone replacement with low-dose exogenous estrogens and a progestin has a 
cardioprotective effect [33].  
 
Lifestyle factors – A diet rich in calories, saturated fat, and cholesterol contributes 
to other risk factors that predispose to coronary heart disease. As noted above, 
weight gain promotes the major cardiovascular risk factors and weight loss improves 
them .   
 
  Exercise – Exercise of even moderate degree has a protective effect against 
coronary heart disease and all-cause mortality [34] .The improvement in survival with 
exercise is equivalent and additive to other lifestyle measures such as cessation of 
smoking, control of hypertension, and avoidance of obesity 
Exercise may have a variety of beneficial effects including an elevation in serum 
HDL-cholesterol, a reduction blood pressure, less insulin resistance, and weight 
loss.  
 
  Cigarette smoking – Cigarette smoking is an important and reversible risk factor 
for CHD. The incidence of a myocardial infarction is increased six fold in women and 
threefold in men who smoke at least 20 cigarettes per day compared to subjects 
who never smoked [35] .On the other hand, the risk of recurrent infarction in a study of 
smokers who had a myocardial infarction fell by 50 percent within one year of 
smoking cessation and normalized to that of nonsmokers within two years[36] . The 
benefits of smoking cessation are seen regardless of how long or how much the 
patient has previously smoked. 
 
  Diet – In addition to the role of dietary lipids in the development of CHD, there is 
growing evidence suggesting that fruit and vegetable consumption and a high fiber 
diet are inversely related to the risk of coronary heart disease (CHD) and stroke . 
High fiber intake is associated with a 40 to 50 percent reduction in the risk of CHD 
and stroke compared to low intake [37] .  
ROLE OF FLAVINOIDS AND ANTIOXIDANTS 
Flavonoids are polyphenolic antioxidants naturally present in vegetables, fruits, and 
beverages such as tea and wine. They have been shown to have anti-inflammatory, 
anti-thrombotic, and vasodilatory activity. In vitro, flavonoids inhibit oxidation of low-
density lipoprotein and reduce thrombotic tendency,  
In a study by Hertog MG et al Flavonoid intake was significantly inversely 
associated with mortality from coronary heart disease and showed an inverse 
relation with incidence of myocardial infarction, 
Flavonoids in regularly consumed foods may reduce the risk of death from coronary 
heart disease in elderly men [38]. 
Obesity – Obesity is associated with a number of risk factors for CHD. These 
include: 
  • Hypertension 
  • Glucose intolerance 
  • Insulin resistance 
  • Hypertriglyceridemia 
  • Reduced HDL-cholesterol 
  • Elevated fibrinogen 
 
Data from many studies have documented the risk in coronary heart disease 
associated with being overweight .Patients with abdominal (central) obesity are at 
greatest risk [39].  
Significantly increased risks of death from cardiovascular disease were found at all 
indices of more than 26.5 kg/m2 in men and 25 kg/m2 in women. The risk is 
increased with a high waist to hip ratio. It was greater for whites than blacks. 
 Plasma fibrinogen – Plasma fibrinogen levels are important predictors of 
cardiovascular disease and there is a linear relationship between fibrinogen and 
traditional cardiovascular risk factors including age, smoking, diabetes, body mass 
index, total and LDL cholesterol, and triglycerides. Data from the Framingham 
Offspring study suggested that measurement of fibrinogen is a useful adjunct 
screening tool to identify individuals at increased thrombotic risk [40].  
C-reactive protein – This is an association rather than a risk factor. It is positively 
associated with future cardiovascular events in healthy as well as high risk individuals. 
 
PRESENTATION OF CAD  
The spectrum of presentation includes symptoms and signs consistent with the 
following conditions: 
o Asymptomatic state (subclinical phase) 
o Stable angina pectoris 
o Unstable angina (i.e., ACS) 
o Acute MI 
o Chronic ischemic cardiomyopathy 
o Congestive heart failure 
o Sudden cardiac arrest 
 
 ANGINA PECTORIS 
PATHOPHYSIOLOGY OF ANGINA 
  Angina is caused by myocardial ischemia which occurs whenever myocardial 
oxygen demand exceeds oxygen supply.  
Any clinical setting or pathologic situation which results in a reduction in myocardial 
oxygen supply can cause ischemia. The most frequent cause is coronary 
atherosclerosis, but others include coronary artery vasospasm and embolism. In 
addition, stimulation of the esophagus by acid can cause coronary artery 
vasoconstriction and a reduction in coronary blood flow via a neural 
cardioesophageal reflex [41]. 
Angina can also occur after eating. Postprandial angina results from a redistribution 
of blood flow, away from territories supplied by severely stenosed coronary arteries 
and to those supplied by less diseased or normal arteries [42] .This may be due to 
sympathetic activation from food ingestion and norepinephrine-induced 
vasoconstriction in diseased vessels. 
 
CLINICAL PRESENTATION OF ANGINA; 
HISTORY – The patient with angina often has a fairly typical history [43]: 
  • Quality of the chest pain – Angina is often characterized more as a discomfort 
than pain, and may be difficult to describe. Terms frequently used by patients 
include squeezing, tightness, pressure, etc. In some cases, the patient cannot 
qualify the nature of the discomfort, but places his or her fist in the center of the 
chest, known as the "Levine sign." 
Angina is typically gradual in onset as the intensity of the discomfort increases over 
several minutes. In contrast, noncardiac pain is often of greatest intensity at its 
onset. 
The discomfort does not change with respiration or position and is generally not 
sharp, dull-aching, knife-like, stabbing, or pins and needles-like. 
  • Location –It is not felt in one specific spot, but rather is a diffuse discomfort that 
may be difficult to localize. The patient often indicates the entire chest, rather than a 
specific area, when asked where the discomfort is felt. 
  • Radiation – It often radiates to other parts of the body including the upper 
abdomen, shoulders, arms, wrist, fingers, neck and throat, lower jaw and teeth, and 
rarely to the back.  
  • Associated symptoms – It is often associated with other symptoms. The most 
common is shortness of breath, which may reflect mild pulmonary congestion 
resulting from ischemia-mediated left ventricular dysfunction [44]. Other symptoms 
may include belching, nausea, indigestion, diaphoresis, dizziness, lightheadedness, 
clamminess, and fatigue. 
  •  Provoking factors – Angina is often elicited by activities and situations which 
increase myocardial oxygen demand, including physical activity, cold, emotional 
stress, sexual intercourse, meals and  cocaine use. 
  •  Timing – Angina occurs more commonly in the morning due to a morning diurnal 
increase in sympathetic tone. Enhanced sympathetic activity raises heart rate, blood 
pressure, vessel tone and resistance, and platelet aggregability. 
 
  •  Duration of symptoms – Angina generally lasts for two to five minutes. It does 
not lasts only for a few seconds or less than a minute, and it generally does not last 
for 20 to 30 minutes, unless the patient is experiencing an acute myocardial 
infarction. 
  •  Relief of discomfort – Factors that reduce oxygen demand or increase oxygen 
supply will result in relief of angina. These include cessation of activity, use of 
nitroglycerin, sitting up (which reduces venous return and preload).  
 
PHYSICAL EXAMINATION – Ischemia can produce myocardial function 
abnormalities which may result in the following findings: 
 
  •  Increase in heart rate – Ischemia can raise the heart rate which may occur even 
if the patient is receiving a beta blocker or calcium channel blocker. This is induced 
by reflex sympathetic nervous system activation as a response to discomfort. 
  •  Elevation in blood pressure – Ischemia often causes a hypertensive response. 
This  is induced by both sympathetic activation  and stimulation of the LAD 
chemoreceptor. 
  •  New heart sounds – The second heart sound may become paradoxically split 
due to delayed relaxation of the left ventricular myocardium and delayed closure of 
the aortic valve. There may also be a third or fourth heart sound. These changes are 
typically transient and disappear upon resolution of ischemia. 
  •  New murmurs – Impaired myocardial function may result in a new mitral 
regurgitation murmur (transient papillary muscle dysfunction) or changes in 
preexisting murmurs.  
  •  Precordial movements – Palpation of the chest wall may reveal abnormal 
pulsations which correlate with transient left ventricular dysfunction. These reflect 
disease of the LAD. 
Palpation of the left anterior chest wall at the anterior axillary line may reveal an 
abnormal tapping in systole, which reflects the presence of an area of dyskinetic 
contraction or aneurysm. Transient right ventricular dysfunction may also manifest 
as a transient right ventricular heave. 
UNSTABLE ANGINA 
This refers to angina of recent onset (less than one month), worsening angina or 
angina at rest [45].Post-myocardial infarction (MI) angina, and angina after a 
revascularization procedure are regarded as part of the spectrum.  
Classification of unstable angina 
In 1989, a classification of unstable angina was introduced [46]; this classification is 
based on the clinical history (accelerated exertional angina or rest pain, the timing of 
the latter in respect to presentation, and the clinical circumstances in which unstable 
angina developed), on the presence or absence of ECG changes, and on the 
intensity of anti-ischemic therapy. (see table) 
 
Table 1. Classification of Unstable Angina 16 
Clinical Circumstances 
Severity 
A—Develops 
in Presence of 
Extracardiac 
Condition That 
Intensifies 
Myocardial 
Ischemia 
(Secondary 
UA) 
B—Develops in 
Absence of 
Extracardiac 
Condition  
(Primary UA) 
C—Develops 
Within 2 wk of 
AMI 
(Postinfarction 
UA) 
I—New onset of severe angina or 
accelerated angina; no rest pain 
IA IB IC  
II—Angina at rest within past month 
but not within preceding 48 h (angina 
at rest, subacute) 
IIA IIB IIC 
 
III—Angina at rest within 48 h (angina 
at rest, acute) 
IIIA IIIB-Tneg  IIIB-Tpos  IIIC  
 
UA indicates unstable angina; AMI, acute myocardial infarction.  
 
Although the development of this classification was based on clinical experience, it has 
been validated in a number of prospective studies. For example, Calvin et al [48] studied 
393 patients with unstable angina and reported that a history of a myocardial infarction 
within 14 days (class C) and ST-segment depression on the presenting ECG were both 
markers of increased risk or complications. 
 Miltenburg-van Zijl et al[49] classified 417 patients with unstable angina and followed 
them up for 6 months. Death or myocardial infarction occurred more frequently in those 
with recent rest pain (class III) and in postinfarction patients (class C). The presence of 
ECG changes and the need for maximal antianginal therapy were also independent 
risk factors. A high unstable angina class (IIIB or IIIC) led to a high rate of coronary 
revascularization.[50] 
However, this classification also has a number of weaknesses including substantial 
overlap between the groups and difficulty in identifying very low risk patients. In 
addition, a number of important clinical considerations are not included, such as the 
presence or absence of electrocardiographic (ECG) changes, age, gender, and the 
presence of comorbid illness known to increase the risk of coronary disease such as 
diabetes or peripheral vascular disease. 
 
In attempt to correct these weaknesses, a recent prospective study separated 1387 
patients into four different classes on the basis of chest pain pattern and ECG 
findings [51] : 
  •  Class IA – accelerated angina without ECG changes 
  •  Class IB – accelerated angina with ECG changes 
  •  Class II – new onset exertional angina 
  •  Class III – new onset rest angina 
  •  Class IV – protracted rest angina with ECG changes 
 
Follow-up demonstrated a progressive increase in cardiac events rate from class I to 
class IV with mortality limited to patients in classes III and IV . 
Taken together with the other clinical and patient variables mentioned, these 
classifications provide a valuable background for approaching a patient with unstable 
angina.  
 
DIAGNOSTIC WORKUP 
 
Following proper clinical assessment, patient with suspected CAD ideally should 
undergo an array of investigations to establish the diagnosis of CAD.   
 
RESTING ECG: 
The electrocardiogram (ECG) remains a mainstay in the diagnosis of acute and 
chronic coronary syndromes. The findings depend upon the duration, extent 
(transmural versus subendocardial), and localization of ischemia or infarction. 
 
ECG-coronary syndromes – There are four major types of acute coronary artery 
syndromes, in which myocardial ischemia leads to different ECG manifestations [52]: 
  •  Noninfarction subendocardial ischemia (classic angina), manifested by transient 
ST segment depressions and T wave inversion. 
  •  Noninfarction transmural ischemia (Prinzmetal's variant angina), manifested by 
transient ST segment elevations. 
  •  Non-Q wave infarction, manifested by ST depressions or T wave inversions 
without Q waves. 
  •  Q wave infarction, manifested by Q waves which are usually preceded by 
hyperacute T waves and ST elevations, and followed by T wave inversions. 
 
LOCALIZATION OF ISCHEMIA OR INFARCTION –  
The pattern of involvement of ECG leads helps in localizing regions of ischemia. 
  •   Involvement of precordial leads (V1-V6), leads I and aVL indicates anterior wall 
ischaemia , 
  •  Leads V1 to V3: anteroseptal ischemia, 
  •  Leads V4 to V6 : apical or lateral ischemia 
  •  Leads II, III, and aVF: inferior wall ischemia 
  •  Right-sided precordial leads : right ventricular ischemia. 
Posterior wall infarction can induces ST elevations in leads placed over the back of the 
heart,  and can be recognized by reciprocal ST depressions in leads V1 to V3. 
 
When the resting ECG is normal or non conclusive in patients who are highly 
suspected to have myocardial ischaemia, exercise ECG is indicated. 
 
 
EXERCISE ECG 
 Main indications: 
• Evaluation of patients with symptoms suggestive of IHD. 
• Assessment of level of exercise at which ischaemic manifestations occur in a patient 
with known IHD. 
Contraindications: 
• Recent MI (4-6 weeks) except for submaximal test, 
• Angina at rest, 
• Rapid arrhythmias, 
• Uncompensated heart failure, 
• Advanced atrioventricular block, 
• Severe aortic stenosis, 
• Bp> 170/100 before the onset of exercise. 
 Procedure: 
Multistage protocols are used that use dynamic exercise on a treadmill up to a 
predicted maximal heart rate for age. These differ in the speed of the treadmill and in 
the duration of each stage of the test. 
ECGs are performed at each stage, immediately post exercise and at 2 minutes 
intervals thereafter for 6-10 minutes. 
A horizontal or down-sloping ST segment that is depressed at least 1mm below the 
isoelectric line at the J point and persists for 80 msec is interpreted as a positive test. 
The workload, heart rate, blood pressure, presence of arrhythmias and symptoms  are 
recorded. 
Decrease in blood pressure, submaximal pulse response, exercise induced pain,  
ventricular ectopy, early onset and  prolonged persistence of ST segment changes:  all 
correlate with more severe disease.[53] 
 ECHOCARDIOGRAPHY 
 
Echocardiography is a valuable measure in evaluation  patients with IHD. Regional 
wall motion abnormalities, indicating previous ventricular damage, can be visualized 
within seconds of a coronary artery occlusion, and occurs prior to the onset of 
electrocardiographic changes or the development of symptoms [54] . Ventricular ejection 
fraction can be calculated and is useful in determining prognosis.  
 
STRESS ECHOCARDIOGRAPHY – Stress echocardiography can be performed 
with exercise, or pharmacologically with  the administration of dobutamine, 
dipyridamole or  other agents.  
Dobutamine echocardiography – Because of the difficulties with exercise 2D 
echocardiography, dobutamine echocardiography has become increasingly popular. 
This procedure is based upon the fact that the myocardial regions perfused by 
arteries with significant stenoses will deteriorate when ischemia is provoked by the 
inotropic and chronotropic effects of dobutamine[55]  . 
Dobutamine stress echocardiography may provide additional information in patients 
with chest pain, a negative initial serum assay for myocardial infarction, a non-
ischemic ECG, and a normal resting echocardiogram. One study in 163 such 
patients found that dobutamine stress echocardiography had a sensitivity, specificity, 
and negative predictive accuracy of 90, 89, and 99 percent, respectively, versus 
clinical and catheterization studies[55] . 
 
 
PERFUSION IMAGING 
 
Myocardial perfusion scintigraphy demonstrates relative myocardial perfusion. It is 
used in conjunction with exercise to detect ischemia. 
The sensitivity of the test in the diagnosis of coronary heart disease (CHD) is 
approximately 90 percent, greater than that achieved with the exercise 
electrocardiogram. Scintigraphy is also useful in evaluating myocardial viability, in 
establishing the "culprit" lesion prior to revascularization, in assessing the 
completeness of revascularization, and in the risk stratification of patients with stable 
CAD, postmyocardial infarction, post-unstable angina, and prior to vascular surgery 
[56]. 
 
The test consists of injecting a radioactive agent (Thallium-201 or Technetium-99) 
which is distributed into the myocardium according to the coronary blood flow and 
uptake characteristics.  
Regions with decreased blood flow are seen as cold spots.  Images taken during rest 
and following exercise are compared to detect areas of reversible ischaemia. 
 
Pharmacologic stress modalities in conjunction with perfusion imaging are used in 
patients who are unable to exercise.  
Dipyridamole, adenosine, and dobutamine have all been extensively studied and 
show sensitivity and specificity generally comparable to exercise perfusion imaging 
[57] Each of these drugs increases myocardial blood flow, the first two by inducing 
primary vasodilatation without producing any significant hemodynamic effects, and 
dobutamine via its positive inotropic and chronotropic actions which lead to secondary 
vasodilatation.  This will produce relative hypoperfusion in the myocardium served by 
stenotic coronary arteries. 
 
(CORONARY ANGIOGRAPHY) 
  
APPROACH TO SPECIFIC CLINICAL SETTINGS  
 
Chest pain at rest – Some patients present with typical chest pain and ECG 
changes that easily establish the diagnosis of unstable angina. Other patients, 
however, present with atypical chest pain and nonspecific ECG findings.  
 
Patients with atypical symptoms, no ECG changes at rest and, especially, during an 
episode of pain, are at a very low risk and can be evaluated on an outpatient basis.  
 
On the other hand, patients with distinct ischemic ECG abnormalities, regional wall 
motion abnormality, and/or perfusion wall defect constitute a high risk group 
requiring close observation and intensive medical therapy, frequently including 
emergent or urgent cardiac catheterization. [58] 
 
New onset angina – Patients with new onset angina, even if only exertional in 
nature, should be treated as if they have a potentially unstable lesion.  
 
Post-MI angina – Angina occurring shortly after myocardial infarction, either Q wave 
or non Q wave, places the patient into a very high risk group for subsequent 
ischemic events and usually requires prompt diagnostic and therapeutic 
interventions [59].  
 
Post-bypass or post-angioplasty angina – Recurrence of anginal chest pain 
symptoms after coronary artery bypass grafting (CABG) or percutaneous 
transluminal coronary angioplasty (PTCA) may signify the development of an acute 
complication, new lesions, graft failure. or post-angioplasty restenosis.  
In both cases, cardiac catheterization is the preferred approach to define the 
problem and to provide a therapeutic intervention.  
 The ACC/AHA published recommendations for therapy and the use of coronary 
angiography in patients with ischemia after revascularization [58].  
 
CORONARY ANGIOGRAPHY 
Coronary angiography is an invasive investigation which is used in the diagnosis and 
management of patients with known or suspected coronary artery disease.  It is useful 
in delineating the exact coronary anatomy especially in those considered for 
revascularization. At present, there is no alternative investigation to conventional 
coronary angiography.[60] 
Main indications are [11]: 
• Angina (refractory and post MI) 
• Acute Coronary Syndrome 
• Uncertain diagnosis  
Procedure  
The basic principle of the procedure is to outline the coronary arteries radiographically 
by transiently filling them with a radio-opaque contrast agent. A sheath is inserted 
percutaneously into a peripheral artery under local anaesthesia through which a fine 
hollow coronary catheter is manipulated, under fluoroscopic guidance, into the 
coronary ostium. Several views are taken, each requiring the hand injection of 5-10 ml 
of contrast agent into the coronary artery. A film of left ventricular myocardial 
contraction, a ventriculogram, is often carried out during the procedure by advancing a 
specific catheter into the left ventricular cavity where a larger volume (35-45 ml) of 
contrast is mechanically injected. Most patients tolerate coronary angiography well with 
little or no sedation 
 
Complications  
Major complications are rare (~1 in 1000) but do include death, myocardial infarction, 
stroke, aortic or coronary dissection, cardiac rupture, air embolus, cardiac arrhythmia 
and peripheral arterial injury. Minor complications are relatively common and include 
haematoma at the site of arterial puncture, short-lived episodes of angina, vasovagal 
reactions, and allergies to contrast agents and drugs.  
Equipment  
In view of the potential complications, the procedure should only be carried out by 
experienced trained operators in a well-equipped and staffed cardiac catheter 
laboratory.. In addition to the x-ray equipment, the catheter laboratory must have 
monitors to allow continuous ECG and intra-arterial pressure recordings as well as full 
resuscitation equipment including a defibrillator, oxygen, suction, and all appropriate 
drugs.  
Personnel  
Staffing of the laboratory requires medical and paramedical personnel including 
radiographers, physiological measurement technicians and nursing staff as well as 
trained medical operators. The experience of the operator and laboratory staff has an 
important influence on the safety and complications of catheter procedures.  
Findings: 
The extent of coronary artery disease is measured by the number of vessels involved 
and the severity of their obstructions. 
 
For each vessel the following are determined: 
o Percentage of occlusion. 
o Site, length and shape of the lesion.  
o Flow, scored according to TIMI classification as follows:  
Grade 0:total occlusion, grade 1:slow and incomplete opacification of the artery portion 
after the lesion, grade 2:slow but complete opacification, grade 3:normal opacification.  
 The American College of Cardiology has defined significant coronary artery disease 
as evidence by angiography of at least 50% narrowing of the lumen of the artery. 
 
 
 
 
ANGIOGRAPHIC MORPHOLOGY 
 
 
AMBROSE'S MODIFIED CRITERIA. 
 
In patients with either stable or unstable angina, the morphology of coronary artery 
lesions can be qualitatively assessed at angiography. Each obstruction reducing the 
luminal diameter of the vessel by 50% or greater can be categorized into one of the 
following morphologic groups [2] :  
1. concentric (symmetric narrowing). 
2. type I eccentric (asymmetric narrowing with smooth borders and a broad neck). 
3. type II eccentric (asymmetric with a narrow neck or irregular borders, or both). 
4.  multiple irregular coronary narrowings in series. 
 
Type II eccentric lesions are frequent in patients with unstable angina and probably 
represent ruptured atherosclerotic plaques or partially occlusive thrombi, or both; 
whereas concentric and type I eccentric lesions are seen more frequently in patients 
with stable angina [2] . 
 
THE ACC/AHA GRADING SYSTEM: 
This was made mainly to predict rate of success and complications in coronary 
angioplasty; the more complex lesions has less success rates and more 
complications. 
 
 
 
 
 
 
CORRELATING ANGIOGRAPHIC FINDINGS  
WITH CLINICAL PRESENTATION 
A correlation between clinical class and coronary anatomy has been described. 
Ahmed et al [6] reported that an "unstable angina score" based on the clinical 
classification was the most important predictor of intracoronary thrombus and lesion 
complexity. 
 Danges et al found that both classes III and C were associated with complex culprit 
artery lesions and reduced TIMI flow [7]. 
Rupprecht et al [10] reported that the incidence of the angiographic evidence of complex 
lesions and/or thrombosis rose progressively with higher unstable angina classes.  
Owa et al[61] found that unstable angina class III was associated with both a higher 
incidence of coronary thrombi on angiography and an increased risk of clinical 
progression to myocardial infarction.  
  Angiographic findings and serum troponin T  
 
– Serum troponin T concentrations may be a sensitive marker for lesion severity and 
TIMI flow. As an example, in the CAPTURE trial of patients with refractory angina, 
those with elevated serum troponin were more likely to have complex lesion 
morphology (type B2 or C) (72 versus 54 percent), visible thrombus (15 versus 4 
percent), and TIMI flow grade <2 (16 versus 5 percent)  than those with negative 
troponin T levels. 
 
Extent of coronary disease in DM 
 In addition to the increased clinical incidence of CHD, the extent of the disease in 
the coronary arteries is also greater among diabetic patients. Autopsy studies have 
reported that diabetic patients, compared to nondiabetics, have a higher incidence of 
two and three-vessel disease (83 versus 17 % in one report) and a lower incidence 
of one vessel disease [62] 
Retrospective analyses of patients undergoing elective percutaneous transluminal 
coronary angioplasty (PTCA) support these data. The diabetic patients had more 
multivessel disease.  
However, not all studies support these findings . One study, for example, compared 
the angiograms of 55 patients with noninsulin-dependent diabetes with 55 
nondiabetic patients of similar age and with similar symptoms [63]; no difference in 
the severity and extent of CHD was observed between the two groups. One possible 
explanation for these results is the inclusion of insulin-dependent diabetics in those 
studies reporting a difference in CHD. 
 
TREATMENT OF CAD 
 
LIFESTYLE MODIFICATION  
• Weight loss and a healthy diet (rich in vegetables and fruits, low in cholesterol )  
• Exercise: Gradual institution of a regular exercise program results in a lower 
oxygen requirement and improves exercise tolerance. 
• Risk factors modification: This includes treatment of hypertension, cessation of 
smoking, and correction of hyperlipidemia and controlling diabetes. 
 
MEDICAL TREATMENT  
Antiplatelets: Aspirin 75- 300 mg daily to decrease risk of thrombosis plus 
clopidogril 75 mg in high risk cases. 
 
Nitrates – Nitrates are a first-line therapy for treatment of acute anginal symptoms. 
They act as venodilators and coronary vasodilators. These effects decrease left 
ventricular systolic wall stress while increasing coronary blood flow[64]. 
Sublingual nitroglycerin is used for acute anginal episodes and prophylactically for 
activities known to provoke angina. Chronic nitrate therapy, in the form of an oral or 
transdermal preparation, reduces the frequency of anginal episodes and improves 
exercise tolerance [65]  
 
Beta blockers – Beta blockers relieve anginal symptoms by inhibiting sympathetic 
stimulation of the heart, reducing both heart rate and contractility .The 
cardioselective beta blockers (such as atenolol and metoprolol) have, in lower 
doses, the advantage of blocking beta-1-receptor mediated stimulation of the heart 
with lesser inhibition of the peripheral vasodilatation and bronchodilatation induced 
by the beta-2 receptors. 
 
Beta blockers are proven to prevent reinfarction and to improve survival in patients 
who have sustained a myocardial infarction [66].  
 
Calcium channel blockers – Calcium channel blockers cause coronary and 
peripheral vasodilatation, decreased atrioventricular (AV) conduction, and reduced 
contractility [67] .  
 They reduce anginal symptoms and increase exercise tolerance, especially when 
used in conjunction with other antianginal agents 
  •  Verapamil is a negative inotrope that also decreases AV conduction. Potential 
side effects include heart block, worsening congestive heart failure, and 
constipation. 
  •  Diltiazem has intermediate effects, being a modest negative inotropic agent and 
vasodilator with a low incidence of side effects. 
  •  The dihydropyridines, such as nifedipine and amlodipine, are potent vasodilators 
with less effect on contractility and AV conduction.  
 
CORONARY REVASCULARIZATION  
 
Percutaneous transluminal coronary angioplasty  
 
This  is  used to dilate  coronary arteries by inflating a balloon with or without 
stenting. 
 It is indicated in patients with single vessel disease, especially if symptoms are 
refractory to medical therapy or if there is a large amount of ischemic myocardium as 
indicated by stress test or perfusion imaging.  
 
In patients with two or three vessel disease and normal left ventricular (LV) function, 
either PTCA or CABG can be performed;  they have similar rates of complications[68] 
. CABG offers the advantages of more complete revascularization, better relief of 
angina, and lower rate of reintervention, although the initial duration of 
hospitalization is longer . 
There are three major contraindications to PTCA [69] . 
  •  More than 50 percent stenosis in the left main coronary artery, 
  •  Diffuse severe multivessel disease, 
  •  Lack of surgical backup. 
 
Complications are abrupt occlusion  and restenosis; both are reduced by stenting.  
Stents 
The use of intracoronary stents in PTCA has resulted in significant reductions in 
acute vessel closure and restenosis. 
Different stents are available and differ in composition (e.g., stainless steel, 
tantalum), design (slotted tube versus coiled wire), and mode of implantation 
(balloon expandable versus self-expanding). 
Newer Drug-eluting stents (DES) consist of a metallic stent backbone, a biostable 
covering, and an anti-restenotic drug that is contained within the polymer and is 
released over a period of 14 to 30 days after implantation to modify the local healing 
response. Clinical trials of sirolimus-eluting stents and paclitaxel-eluting stents have 
demonstrated a marked reduction in the incidence of restenosis. 
 
CORONARY ARTERY BYPASS SURGERY  
 
The main indications for this procedure are: 
 
  • More than 50 percent stenosis of the left main coronary artery. 
  • Angina that is refractory to maximal medical therapy and not amenable to 
percutaneous revascularization. 
  • Severe ischemia in patients with LV dysfunction in whom complete 
revascularization is better achieved with CABG. 
 • Abrupt closure complicating PTCA in which there is a moderate to large amount of 
myocardium at risk. 
  • Three vessel disease and LV dysfunction . 
 Patients with three vessel disease, normal LV function, and moderate to severe 
ischemia by noninvasive testing would probably also benefit from surgery, although 
the outcome is not clearly better than multivessel angioplasty. 
  • Two vessel disease involving the proximal left anterior descending with a 
moderate size of myocardium at risk, unless angioplasty can be done safely [70] . 
 
In the procedure the obstruction is bypassed by internal mammary artery or a 
reversed saphenous vein graft (long term patency is less).  
Minimal invasive coronary bypass (MIDCAB) is being developed, ith no need for 
extracorporal circulatory support. 
 
RATIONALE 
 
Coronary Artery Disease is a serious condition and 
nowadays is increasingly recognized in Sudanese patients 
with the improved health care system and diagnostic tools. 
This is especially so in patients with recognized risk 
factors for ischaemia e.g. diabetes, which is an increasing 
problem in the country. 
The recent availability of Catheter labs enables fast and 
accurate diagnosis of CAD, and delineates the exact 
coronary anatomy allowing proper intervention and thus 
decreasing morbidity and probably improving survival. 
The aim of this study is to explore whether a specific 
presentation in patients with CAD correlates with a more 
severe form of coronary involvement, in which case 
prompt action would be needed. 
OBJECTIVES 
 
• To identify lesion morphology in patients with 
coronary artery disease undergoing coronary 
angiography. 
• To correlate angiographic findings with the 
different clinical presentations: 
? Stable against unstable Angina. 
? Diabetics against non-diabetics. 
CHAPTER TWO
 
METHODOLOGY 
 
 
 
Study Design: 
This study, a Prospective one, was conducted in Ahmed Qasim Hospital, 
from 1st of January   to 30th of June 2005. 
 
Study Population: 
This included all patients with coronary artery disease who underwent 
coronary angiography. 
 
Exclusion criteria: 
Patients with CAD who underwent the procedure, and had no clinical data 
regarding mode of presentation.  
 
Methods: 
Information was collected using data sheet to show: 
Demographic data, risk factors, complaints, physical examination,  ECG 
changes at time of presentation and echocardiography findings. 
The recordings of the actual angiographies were revised and morphology 
of coronary artery lesions was assessed. Each obstruction reducing the 
luminal diameter of the vessel by 50% or more was categorized using 
Ambrose's modified criteria.  
 
 
Reduced Ejection Fraction was defined as ejection fraction <45% [11]. 
 
CHAPTER THREE
RESULTS 
 
• Total number of patients studied 105; men (n=59), women (n=46).  
[Fig 1] 
• Age ranged between 30-85 years. Mean age 59 years. [Fig 2] 
• Regarding Risk Factors: 54% were hypertensive, 34% smokers, 29% 
diabetics and 15% had family history of ischaemic heart disease. 
[Fig 3] 
• 53% of  patient(n=56) presented with chest pain together with other 
symptoms, 31(30% )with chest pain alone,15(14%)with symptoms other 
than chest pain and 3(3%) were asymptomatic. [Fig 4] 
• Out of 87 patients presenting with chest pain, only 73 could be classified 
into stable 60% and unstable angina 40%.[Fig 5] 
 
Angiographic Findings: 
• 46 patients had normal coronaries while 58 had significant disease. 
According to Ambrose modified criteria, the coronary lesions were simple 
in 20(34%) and complex in 38 (66%).[Fig 6] 
 
• 41 patients had both angina and established CAD: 22 stable and 19 
unstable. 
In patients with stable angina 36.4% had simple lesions, 63.6% had 
complex lesions. In those with unstable  angina 36.8% of the lesions 
were simple and 63.2% were complex (p= 0.96 ) [table 1] 
 
• The number of vessels involved were as follows:  
In stable angina, 31.8% single vessel , 22.7% two vessels, and 45.5% 
three vessels. 
In unstable angina; 31.6%, 21.1% and 47.4% respectively.(p=0.98) 
[table2]  
 
Comparing findings between diabetics and non diabetics: 
•  Patient without diabetes  36.8% had simple lesions while 63.2% had 
complex lesions. In diabetics the values were 30% and 70% 
respectively. (p=0.60) [table3 ]  
• The number of vessels involved were as follows: 
In non diabetics: 16.2% single vessel, 13.5% two vessels and 21.6% 
three vessels. 
In diabetics: 16.7%, 6.7% and 43.3% respectively.(p=0.13)  [Fig7] 
Prevalence of three vessel disease among diabetics was tested against 
single, and two vessel disease; this was not statistically significant 
(p=0.4, and 0.2 respectively). [table: 4,5] 
 
• Correlating number of vessels involved to ejection fraction:  
Normal EF was found in 13 patients:  4(31%) had single vessel disease, 
3(23%) two vessel disease, and 6(46%) three vessel disease. 
Reduced EF was found in 12 patients :  1(8%) had single vessel disease, 
2(17%) two vessel disease, and 9(75%) three vessel disease.(p=0.27) 
[Fig:8] 
 
Three vessel disease [more prevalent among patients with low EF (75% 
against 46%)] was tested against prevalence of single vessel, and two 
vessel disease; this was not statistically significant (p=0.3, and 0.7 
respectively).[table:6,7] 
 
 
 
• In 16 patients with past history of MI, 13(81%) had complex lesions and 
3(19%) had simple lesions [Fig10]. In those without history of MI(n=40), 
18(45%) had simple lesions and 22(55%)  complex lesions.(p=0.13)  
 
• For patients with MI 2(13%)  had single vessel disease, 2(13%) had two 
vessel disease and 12(74%) three vessel disease[Fig 11].In those 
without MI 14 (35%) had single vessel disease, 11(28%) had two vessel 
disease and 15(37%) three vessel disease. (p=0.015) significant. 
 
• ECG: showed changes suggestive of ischaemia in 57% of patients with 
established CAD.(p=0.58)  
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Correlation between Type of Angina and 
Lesion Morphology 
 
 
 
  Simple Complex Total 
Stable 8(36.4%) 14(63.6%) 22(100%) 
Unstable 7(36.8%) 12(63.2%) 19(100%) 
 
(p= 0.96 ) 
 
 
 
 
 
 [Table1] 
 
 Correlation between Angina and Number of 
Vessels Involved  
 
 
 
 
  svd 2vd 3vd Total 
Stable Angina 7(31.8%) 5(22.7%) 10(45.5%) 22(100%)
Unstable Angina 6(31.6%) 4(21.1%) 9(47.4%) 19(100%)
 
(p=0.98) 
 
 
 
[Table2] 
 
Lesion morphology in Patients with and 
without Diabetes 
 
 
 
 
 Simple Complex Total 
No DM 14(36.8%) 24(63.3%) 38(100%) 
DM 6(30.0%) 14(70.0%) 20(100%) 
 
(p=0.60)  
 
 
 
 
[Table3] 
Number of  Vessels  Involvement in Patients wit
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Fig:7 
 Comparing Single and Three vessel disease 
in patients with and without DM 
 
 
 
 
 
 
  
svd 
 
3vd 
 
Total 
No DM 12(42.9%) 16(57.1%) 28(100.0%) 
DM 5(27.8%) 13(72.2%) 18(100.0%) 
(p=0.471) 
 
 
[Table:4] 
 
 
 
Comparing Two and Three vessel disease 
in patients with and without DM 
 
 
 
 
 
 2vd 3v Total 
No DM 10(38.5%) 16(61.5%) 26(100.0%) 
DM 2(13.3%) 13(86.7%) 15(100.0%) 
(p=0.178) 
 
 
 
[Table:5] 
Correlating reduced EF with Number of Vessels 
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(p =0.277) 
Fig:8 
Comparing Single and Three vessel disease 
in patients with Normal and Reduced EF: 
 
 
 
 
  
svd 
 
3vd 
 
Total 
Normal EF 4(40%) 6(60%) 10(100%) 
Reduced EF 1(10%) 9(90%) 10(100%) 
 
(p=0.30) 
 
[Table:6] 
 
            
 
 
Comparing Two and Three vessel disease 
in patients with Normal and Reduced EF: 
 
 
 
 
 2vd 3vd Total 
Normal EF 3(33%) 6(67%) 9(100%) 
Reduced 
EF 
2(18%) 9(82%) 11(100%) 
 
(p=0.79) 
 
[Table:7] 
Correlating Reduced EF with Type of Ve
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Type of Lesion 
 in patients with and without MI: 
 
 
 
 
 
 
 Simple Complex Total 
No MI 18(45%) 22(55%) 40(100%) 
MI 3(19%) 13(81%) 16(100%) 
 
(p=0.13) 
[Table:8] 
 
No of diseased vessels in pt. with
13%
13%
74%
Fig:11 
 
 
 
Number of Vessels Involved in Patients with 
and without MI: 
 
 
 
 
  
svd 
 
2vd 
 
3vd 
 
Total 
 
No MI 14(35%) 11(27.5%) 15(37.5%) 40(100%)
 
MI 2(12.5%) 2(12.5%) 12(75%) 16(100%)
 
(p=0.018) significant. 
 
 
[Table:9] 
CHAPTER FOUR
DISCUSSION 
 
 
In our study most patients were found to have complex lesions 66%, while 
only 34% had simple lesions. 
 
• Complex lesions were more common in both stable (63.6%), and 
unstable angina (63.2%) patients. There was no statistical 
difference when associating lesion type to angina class. 
 
This result is in contrast to Ambrose et al.[2] who studied 110 patients with 
either stable or unstable angina, the morphology of coronary artery lesions 
was qualitatively assessed at angiography. Each obstruction reducing the 
luminal diameter of the vessel by 50% or greater was categorized  
according to Ambrose modified criteria. 
In patients with unstable angina or non-Q myocardial infarction, the culprit 
lesion morphology was eccentric type II in 65-70%and concentric in 
30%while in patients with stable angina the percentages were 16%and 
80%respectively. 
For the entire group, type II eccentric lesions were significantly more 
frequent patients with unstable angina (p <0.001), whereas concentric and 
type I eccentric lesions were seen more frequently in patients with stable 
angina (p <0.05).  
 
• Still the percentage of complex lesions in patients with unstable angina 
is similar to that in Ambrose study: 64% and 65% respectively. 
 A similar value 67% was obtained in the study done by Ben-Hamda et al 
[71] which compared the clinical presentation and angiographic morphology 
of patients with unstable angina pectoris.  
 In 321 patients the morphology of coronary artery lesions was classified 
according to Ambrose's classification, 100 patients had simple lesions 
(type I or IIA), and 204 patients had complex lesions (type IIB, III, 
intracoronary thrombus or total occlusion). P value 
Here again, high class unstable angina, i.e. thoracic rest pain (class 
III) or post infarction angina (class C), were associated with the presence 
of complex lesions.  
• On the other hand two further studies concluded that morphology of 
lesions in coronary angiography did not differ significantly in different 
clinical classes of angina. 
The first by Calton R. et al [72] studied 100 patient with unstable angina 
trying to correlate Braunwald's clinical classification of unstable angina 
pectoris with angiographic extent of disease, lesion morphology and intra-
luminal thrombus. 
Morphology of coronary artery lesions was classified according to 
Ambrose's classification. Concentric lesions were found to be higher in 
class C as compared to class B (40% vs. 19.8%; p = 0.014). Statistically 
significant difference was not present in the distribution of other 
morphological type of lesions among different clinical classes. In the whole 
study group, intra-luminal thrombus was found to be present in 17 (17%) of 
patients. Distribution of intra-luminal thrombus according to Braunwald's 
classification showed that none of the patients in class I had intra-luminal 
thrombus, while 13 (19.1%) patients in class II and 4(26.7%) in class III had 
intra-luminal thrombus. There was significant difference in the presence of 
intra-luminal thrombus between class I and class II (p = 0.004) and class I 
and class III (p = 0 .03 was found to be significant). Intra-luminal thrombus 
was more frequently encountered with acute rest angina. However, the 
distribution of different morphological type of lesions on coronary 
angiography did not differ significantly in different clinical classes of 
unstable angina pectoris divided according to Braunwald's classification. 
The second study by Pim J. de Feyter et al[73] assessed coronary lesions 
in patients with stable and unstable angina using coronary angiography, 
intracoronary angioscopy and determined their compositions with 
intracoronary ultrasound. 
In 44 patients with unstable and 23 patients with stable angina, the 
angiographic images were classified as noncomplex (smooth borders) or 
complex (irregular borders, multiple lesions, and thrombus). Angioscopic 
images were classified as either stable (smooth surface) or thrombotic (red 
thrombus). The ultrasound characteristics of the lesion were classified as 
poorly echo-reflective, highly echo-reflective with shadowing, or highly 
echo-reflective without shadowing. There was a poor correlation between 
clinical status and angiographic findings. An angiographic complex lesion 
(n=33) was concordant with unstable angina in 55% (24 of 44); a non 
complex lesion (n=34) was concordant with stable angina in 61% (14 of 
23). There was a good correlation between clinical status and  angioscopic 
findings. An angioscopic thrombotic lesion (n=34) was concordant with 
unstable angina in 68% (30 of 44); a stable lesion (n=33) was concordant 
with stable angina in 83% (19 of 23). The ultrasound-obtained composition 
of the plaque was similar in patients with unstable and stable angina.  
So the conclusion was that angiography discriminates poorly between 
lesions in stable and unstable angina. Angioscopy demonstrated that 
plaque rupture and thrombosis were present in 17% of stable  angina and 
68% of unstable angina patients. Currently available ultrasound 
technology does not discriminate stable from unstable  plaques.     
• In our study the percentage of patients with stable angina who were 
found to have complex lesion was high in comparison with all the other 
studies, those which found a correlation with clinical presentation and 
those which did not. 
A possibility is that definition of stable angina cases here depended on the 
description of pain developing on exertion which may still include lower 
classes of unstable angina e.g., new onset angina and worsening angina. 
So there may be some cases included in the ‘stable angina’ category that 
rather be included in the ‘unstable’ category. Great difficulty was 
encounterd in collecting the history data from the notes. 
Another possibility is the behaviour of atherosclerosis in our patients which 
may be different genetically; however this has not been studied. 
• Three vessel disease was the commonest in the two groups of 
angina with similar pattern of vessel involvement. 
• There was no correlation between angina class and number of 
vessels involved. 
The study by Calton et al[72] , mentioned above, has also compared the 
extent of  vessel involvement in different angina classes. 
 On coronary angiography, 26 (26%) patients had single vessel disease, 30 
(30%) double vessel disease and 39 (39%) patients had triple vessel 
disease. Five (5%) patients were found to have normal coronaries. 
Classification of patients according to Braunwald's clinical classification 
showed single vessel disease to be higher in class I as compared to class II 
(47% vs. 22%; p = 0.04) and classes III (47% vs. 20%; p<0.01). Single 
vessel disease was found to be higher in class C as compared to class B 
(41.7% vs. 16.4; p = 0.01). Two vessel disease was higher in class B as 
compared to class A (40.8% vs. 18.5%, p = 0.04). Triple vessel disease 
incidence was not found to be significantly different among different clinical 
classes. 
Ben-Hamda et al  studied 321 patients with unstable angina found 
that 148 (46%) patients had single vessel disease, double-vessel in 
92(29%) and triple-vessel in 64(20%). No correlation with angina class 
was made. 
Stylianos A. et al[74] studied the potential correlation between the 
angiographic lesion morphology and the early and one year clinical 
outcome in patients with unstable angina, found one-vessel disease in 46 
(37%)patients, two-vessel disease in 40 (32%)patients, three-vessel 
disease in 36 (29%)and left main stem disease in 3 (2%). 
 
In all these studies there was no specific pattern of vessel involvement in 
patients with unstable angina and no correlation with angina class was 
made. 
 
 
 
• Comparing diabetics and non diabetics complex lesions were 
more in diabetics: 70% and 63%. The difference was not statistically 
significant. However there was marked prevalence of complex lesions 
among diabetics.  
• Pattern of vessel involvement showed three vessel disease to be  
more common among diabetics, 43% against 21%.The prevalence of 
three vessel disease was compared to that of single vessel and two 
vessel disease but these were not significant. 
• The results of our study were similar to that by Pajunen P et al [75] 
which compared the angiograms of 55 patients with noninsulin-
dependent diabetes with 55 nondiabetic patients of similar age and 
with similar symptoms. No difference in the severity and extent of CHD 
was observed between the two groups.  
 
However, many studies found that the extent of the disease in the 
coronary arteries is greater among diabetic patients[76]. Autopsy studies 
have reported that diabetic patients, compared to nondiabetics, have a 
higher incidence of two and three-vessel disease (83 versus 17 percent 
in one report) and a lower incidence of one vessel disease [62]. 
 
Retrospective analyses of patients undergoing elective percutaneous 
transluminal coronary angioplasty (PTCA) support these data. One 
study, for example, retrospectively analyzed data on 1133 diabetic and 
9300 nondiabetic patients undergoing PTCA [77] .The diabetic patients 
had more multivessel disease. Furthermore, the likelihood of remaining 
free of infarction or additional revascularization at five years was much 
lower in diabetics (36 versus 53 percent). 
 
These findings are supported by two large-scale thrombolytic trials that 
have provided coronary angiographic data obtained during an acute 
myocardial infarction [78,79]. In the Thrombolysis and Angioplasty in 
Myocardial Infarction (TAMI) trial included 148 diabetics and 923 
nondiabetic patients in whom cardiac catheterization was performed at 
90 minutes and 7 to 10 days after thrombolytic therapy [78]. Compared to 
the nondiabetics, the diabetic patients had a greater incidence of 
multivessel disease (66 versus 46 percent, p=0.0001) and a greater 
number of diseased vessels. 
 
 
•  On correlating the number of vessels involved to ejection fraction 
(EF), three vessel disease was more common (75%) among 
patients with reduced EF compared to those with normal EF(46%). 
No statistical significance as established. Main vessels involved were 
the same in both groups. 
So in this study reduced ejection fraction is associated more with three 
vessel disease (thus extensive myocardial ischaemia).  
 
• In patients with past history of MI, complex lesions were the 
majority at 81%. 
• Most patients with history of MI had three vessel disease (75%). 
This was highly significant when compared to single and two 
vessel disease( p=0.018) 
So patients who developed MI have both marked complexity of the lesions 
and more extensive involvement of the coronaries. 
  
• ECG: showed changes suggestive of ischaemia in only 57% of 
patients with established CAD. (p=0.58)  
This is in keeping with a study done by Weston MJ et al [80] that ECG is not 
a reliable method for detection of CAD. 
  In a retrospective series  Norell M et al [81] studied 250 patients who 
presented to a cardiology clinic for evaluation of recent onset chest pain, 
20 percent of those with normal ECGs were found to have unstable 
angina; one-third of patients diagnosed with unstable angina had a 
normal ECG.The false-negative rate was lower in a prospective series of 
emergency department patients presenting with chest pain; only 4 
percent of those with a normal ECG were found to have unstable 
angina, but strict criteria were used to define the "normal" ECG [82] .  
 
 
 
 
STUDY LIMITATIONS 
 
Certain factors (e.g. cost) make coronary angiography not readily 
accessible to some patients. Possibly those with the more  severe and 
persistant symptoms are the ones who eventually underwent the 
procedure, which may have introduced bias. 
Assessement of the patients’ clinical presentation in our study depended 
mainly on previously recorded data. This was deficient in many aspects 
and did not include the details necessary for classification of angina (e.g. 
duration of symptoms). This may explain the dominance of the complex 
lesions in this study. 
 
 
 
 
 
 
CONCLUSIONS 
 
 
 
 
• The commonest presenting symptom was chest pain. 
• Most lesions in this study were complex lesions. 
• Lesion morphology was similar in patients with stable and 
unstable angina. Number of vessel involvement was also 
similar. 
• Diabetes is associated with more extensive coronary 
involvement i.e. more complex lesions and higher prevalence 
of three vessel disease. 
• Myocardial infarction is more common in patients with three 
vessel disease. 
RECOMMENDATIONS 
 
 
 
• Data in the clinical records should be more detailed especially 
regarding the duration and severity of symptoms since this is 
crucial in risk stratification of cardiac cases . 
 
• In studies where history-based information is needed, data is 
better collected through personal interviews. 
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